Clinical trial
Protein Biomarker in Hepatocellular Carcinoma
NCT00465842 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated
Key facts
| NCT number | NCT00465842 |
|---|---|
| Title | Protein Biomarker in Hepatocellular Carcinoma |
| Official title | Protein Biomarkers for Early Detection and Prognostication in Hepatocellular Carcinoma (HCC) |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | Singapore Cancer Society |
| Status | Terminated |
| Study type | Observational |
| Conditions | Normal Volunteers, Hepatitis, Liver Cirrhosis, Hepatocellular Carcinoma |
| Enrollment | 211 |
| Start date | Jun 20, 2006 |
| Primary completion | Aug 14, 2013 |
| Completion | Aug 14, 2013 |
| First posted | Apr 25, 2007 |
| Last update posted | Feb 15, 2019 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: